Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan

• Published in: International journal of infectious diseases Vol. 115; pp. 30 - 34
• Main Authors: Jian, Ming-Jr, Perng, Cherng-Lih, Chung, Hsing-Yi, Chang, Chih-Kai, Lin, Jung-Chung, Yeh, Kuo-Ming, Chen, Chien-Wen, Hsieh, Shan-Shan, Pan, Pin-Ching, Chang, Hao-Ting, Chang, Feng-Yee, Ho, Ching-Liang, Shang, Hung-Sheng
• Format: Journal Article
• Language: English
• Published: Canada Elsevier Ltd 01.02.2022; The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases; Elsevier
• Subjects: Antigens, Viral; B.1.1.7 lineage; Community transmission; COVID-19; Humans; Rapid antigen test; Reverse Transcriptase Polymerase Chain Reaction; Reverse transcription polymerase chain reaction; SARS-CoV-2; Sensitivity and Specificity; Taiwan - epidemiology; Taiwan; COVID-19; SARS-CoV-2; B.1.1.7 lineage; Rapid antigen test; Reverse transcription polymerase chain reaction; Community transmission

•The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) B1.1.7 lineage was prevalent in April 2021 and spread into Taiwan.•The coronavirus disease 2019 (COVID-19) Antigen Rapid Test Kit (ART) can detect SARS-CoV-2 B.1.1.7 variants.•ART can be used in densely populated areas for symptomatic...